Affinity Asset Advisors, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $579 Million distributed in 86 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Xenon Pharmaceuticals Inc. with a value of $45M, Nuvalent, Inc. with a value of $34.5M, Arcellx, Inc. with a value of $33.4M, Alkermes Plc. with a value of $28M, and Teva Pharmaceutical Industries LTD with a value of $25.2M.

Examining the 13F form we can see an decrease of $156M in the current position value, from $735M to 579M.

Affinity Asset Advisors, LLC is based out at New York, NY

Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $579 Million
Healthcare: $579 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 86
  • Current Value $579 Million
  • Prior Value $735 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.